1. Furst DE, Ulrich RW, Varkey-Altamirano C. Nonsteroidal Anti-Inflammatory Drugs, Disease Modifying Antirheumatic Drugs, Nonopioids Analgesics, & Drugs Used in Gout. Basic and Clinical Pharmacology. 11th ed. New Delhi, India: Tata McGraw Hill Education Private Limited; 2009. Page: 626.
2. Grosser T, Smyth E, FitzGerald GA. Anti-Inflammatory, Antipyretic, and Analgesic Agents; Pharmacotherapy of Gout. Goodman & Gilman’s: The Pharmacological Basis of Therapeutics. 12th ed. New York, New York: McGraw-Hill Medical; 2011. Page: 986-987.
3. Briggs GG, Freeman RK, editors. A Reference Guide to Fetal and Neonatal Risk: Drugs in Pregnancy and Lactation. 10th ed. Philadelphia, PA: Wolters Kluwer Health; 2015. Page:295-297.
4. Garnock-Jones KP. Diclofenac potassium powder for oral solution: a review of its use in patients with acute migraine. Aug 1, 2014; [Accessed on Jan 21, 2021] https://europepmc.org/article/med/25034250
5. Mipharm S.p.A. Depomed, Inc. 1988. U.S. Food & Drug Administration [Revised on May, 2016] [Accessed on Jan 21, 2021] https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/022165s011lbl.pdf